logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Ofsted failing on safeguarding?

24 June 2014

You know there must be concerns with Ofsted’s approach to safeguarding when heads, such as Gareth Dawkins, are critical of Ofsted for not being more robust when inspecting safeguarding in schools. I agree with Gareth. Our education clients tell us that when it comes to safeguarding, inspectors focus unduly on checking that the single central record has been accurately completed and that no dates or initials are missing, rather than satisfying themselves that the school has strong safeguarding practices.

DBS checks are important, but they are not a magic shield, nor are they evidence of good safeguarding in schools. Inspectors ought to review a safeguarding issue to check that guidance was followed, that the local authority was involved and that if the duty was triggered, a referral was made to the DBS. Having done that, a conversation with the head and the designated senior person around what they learnt from that issue and whether it influenced future practice should take place.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up